Table 2

Yearly changes in FEV1 and DLCO before and after pregnancy

SubjectFEV1
(% pred)
DLCO
(% pred)
∆FEV1
(mL/year)
∆FEV1
(%/year)
∆DLCO
(mL/min/ mm Hg/year)
∆DLCO
(%/year)
PregnancyBeforeBeforeAfterBeforeAfterBeforeAfterBeforeAfter
21.6 (53)13 (48)−231−198−6.8−5.99−1.76−1.55−5.9−3.9
32.6 (77)20 (82)−184−284−4.7−7.9−0.99−0.93−2.9−2.6
42.8 (78)18 (57)−29−173−0.27−4.2−0.3−0.71−0.69−2.0
52.5 (76)18 (66)−546−315−17.8−10.2−3.3−2.59−11.8−9.3
83.4 (102)17 (57)−227−420−6.0−11.9
92.8 (96)19 (72)−37−66−0.46−1.50.78−0.99−3.293.3
103.3 (115)29 (132)50−4810.8−0.873.7-217.1−8.6
122.8 (98)19 (89)−44−95−0.7−2.6−0.66−0.78−2.5−3.2
133.4 (104)21−252−0.9−4.7
142.1 (62)15 (63)−84−151−1.8-4−0.53−0.81−1.88−3.0
151.7 (64)11 (53)−96−165−2.6−5.6−1.17−0.96−4.8−4.2
162.0 (83)17 (87)−43−157−0.7−6.0−0.24−0.98−0.6−4.3
  • Data shown only include measurements taken when not receiving an mTOR inhibitor. Subject numbers correspond to table 1 and the figure 1. ∆FEV1 rate of change of FEV1 (mL/year) and per cent predicted/year (%/year). ∆DLCO rate of change of DLCO (mL/min/mm Hg/year).

  • FEV1, forced expiratory volume in 1 s.